JSPR - Wall Street Estimates - Jasper Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 5.98

0.843 %

$ 89.7 M

Market Cap

-1.22

P/E

Price Target Average

907.53%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

2.11%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Jasper Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for JSPR of $60.2 , with forecasts ranging from a low of $48 to a high of $65 .

JSPR Lowest Price Target Wall Street Target

48 USD 702.68%

JSPR Average Price Target Wall Street Target

60.2 USD 907.53%

JSPR Highest Price Target Wall Street Target

65 USD 986.96%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free